EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Characterization of Endometrial Cancer Using a Laboratory-Developed Multi-Gene NGS Panel

Thais Maloberti iD, Annalisa Altimari iD, Elisa Gruppioni iD, Laura Poppi, Viviana Sanza, Alessia Costantino, Sara Coluccelli iD, Giulia Calafato iD, Floriana Jessica Di Paola iD, Caterina Ravaioli iD, Angelo Gianluca Corradini, Marco Grillini iD und 7 weitere

International Journal of Molecular Sciences · 18.08.2026 · 27 (16) · 7384

DOI: 10.3390/ijms27167384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.08.2026. Verfasst von Thais Maloberti und 18 weiteren Autor:innen. Beteiligte Einrichtung: Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Endometrial Neoplasms, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial carcinoma is a biologically and clinically heterogeneous neoplasm, for which molecular classification now plays a central role in determining prognosis and guiding treatment. The aim of this study was to develop and apply an in-house multi-gene NGS panel to expand the molecular characterization of endometrial tumors beyond the markers required for surrogate classification. Seventy primary endometrial carcinomas were selected and analyzed by immunohistochemistry for p53, mismatch repair proteins, ARID1A, and PTEN, and by NGS on DNA extracted from FFPE samples using a panel comprising 28 genes. Molecular classification was assigned according to the WHO algorithm into the subgroups POLE-mutated, MMR-deficient, p53-abnormal, and NSMP (No Specific Molecular Profile). Sixty-eight cases were evaluable by sequencing, and in 93% at least one pathogenic, likely pathogenic, or variant of uncertain significance was identified. The most frequent alterations involved PTEN, PIK3CA, ARID1A, and TP53. POLE-mutated tumors showed the highest mutational burden, while CTNNB1 alterations were predominantly associated with the NSMP subgroup. Overall, the proposed panel proved to be a useful tool for complementing conventional molecular classification and for highlighting additional genomic differences that may be biologically and clinically relevant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsHigh-Throughput Nucleotide SequencingHumansFemaleMutationDNA-Binding ProteinsTranscription FactorsBiomarkers, TumorPTEN PhosphohydrolaseMiddle AgedAgedTumor Suppressor Protein p53Aged, 80 and overNuclear ProteinsAdult

Stichwörter der Autor:innen

endometrial cancermolecular characterizationmolecular sub-groupsmutationsnext-generation sequencing

Substanzen

ARID1A protein, humanDNA-Binding ProteinsTranscription FactorsBiomarkers, TumorPTEN PhosphohydrolaseTumor Suppressor Protein p53PTEN protein, humanNuclear Proteins

Autor:innen und Institutionen

  • Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy.
  • Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Addarii Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Thais Maloberti, Annalisa Altimari, Elisa Gruppioni, Sara Coluccelli, Giulia Calafato, Floriana Jessica Di Paola, Caterina Ravaioli, Marco Grillini, Pierandrea De Iaco, Claudio Zamagni, Giovanni Tallini, Antonio De Leo, Dario de Biase

Förderung

  • Ministry of Health
  • Italian Ministry of Health

Zitieren

APA

Maloberti, T., Altimari, A., Gruppioni, E., Poppi, L., Sanza, V., Costantino, A., Coluccelli, S., Calafato, G., Di Paola, F. J., Ravaioli, C., Corradini, A. G., Grillini, M., Perrone, A. M., De Iaco, P., Rubino, D., Zamagni, C., Tallini, G., De Leo, A., & de Biase, D. (2026). Molecular Characterization of Endometrial Cancer Using a Laboratory-Developed Multi-Gene NGS Panel. International Journal of Molecular Sciences, 27(16), 7384. https://doi.org/10.3390/ijms27167384

Vancouver

Maloberti T, Altimari A, Gruppioni E, Poppi L, Sanza V, Costantino A, et al. Molecular Characterization of Endometrial Cancer Using a Laboratory-Developed Multi-Gene NGS Panel. International Journal of Molecular Sciences. 2026;27(16):7384. doi:10.3390/ijms27167384

BibTeX
@article{Maloberti2026,
  author = {Maloberti, Thais and Altimari, Annalisa and Gruppioni, Elisa and Poppi, Laura and Sanza, Viviana and Costantino, Alessia and Coluccelli, Sara and Calafato, Giulia and Di Paola, Floriana Jessica and Ravaioli, Caterina and Corradini, Angelo Gianluca and Grillini, Marco and Perrone, Anna Myriam and De Iaco, Pierandrea and Rubino, Daniela and Zamagni, Claudio and Tallini, Giovanni and De Leo, Antonio and de Biase, Dario},
  title = {Molecular Characterization of Endometrial Cancer Using a Laboratory-Developed Multi-Gene NGS Panel},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7384},
  doi = {10.3390/ijms27167384}
}
Kostenlos starten →